@xconomy.com 5 months ago
Neurocrine Gets FDA Nod for Once-Daily “Add-On” Parkinson’s Pill
@xconomy.com 5 months ago
Bio Roundup: Fast FDA Approvals, Biogen Delays, ORIC’s IPO & More
@xconomy.com 11 months ago
Disc Medicine Launches With $50M to Advance New Anemia Treatments
@xconomy.com 11 months ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com 11 months ago
Nobel Prize in Medicine Goes to 3 Who Showed How Cells Sense Oxygen Levels
@geekwire.com 12 months ago
Fred Hutch spinout SEngine raises $5.1M to test cancer treatment drugs against a patient’s tumors
@techcrunch.com 1 year ago
Neurobehavioral health company Blackthorn pulls in $76 million from GV to treat mental disorders
@xconomy.com 1 year ago
Bio Roundup: $74B for Celgene, Two CAR-T Tales, Ready for SF & More
@xconomy.com 1 year ago
San Antonio Develops “Action Plan” to Draw Life Sciences Businesses
@xconomy.com 1 year ago
Synthorx Files for IPO to Advance Enhanced Cytokine Drugs
@techcrunch.com 1 year ago
Weed in space is going to be a thing now
@xconomy.com 2 years ago
Verana Health Lands $30M Financing Led By GV, Adds Miki Kapoor as CEO
@techcrunch.com 2 years ago
Implantable 3D printed organs could be coming sooner than you think
@xconomy.com 2 years ago
Fixing the Clinical Trial Bottleneck by Making Patients a Priority